Vivos CEO Explains Breakthrough Sleep Apnea Tech and Path to Profitability | VVOS

YY Group Wins Singapore Infrastructure Contract Worth Up to $5M

CISO Global Seeks SEC Clarity on Share Lending Program for Investor Control

NeOnc Breaks Through Brain Cancer Treatment with Intranasal Drug Delivery

T-Rex Acquisition Refinances Idaho Data Center to Fuel Crypto Mining Expansion

Medicus Pharma Launches 12-Part Media Campaign With New to The Street | MDCX

New to The Street Renews Media Partnership With Acurx Pharma for Investor Outreach

NRX Pharma Nears FDA Approval for Ketamine Drug After Positive Label Review

Medicus Pharma Submits Phase 2 Study Design for Teverelix in Prostate Condition

HPB and Jonas & Redmann Partner to Scale Next-Gen Solid-State Battery Production

Acurx Pharma Targets C. diff With Fast-Track Trial Strategy and Breakthrough Antibiotic

YY Group Targets 10x Revenue Growth in Hong Kong With AI Workforce Platform

Medicus Pharma Celebrates Nasdaq Milestone as It Advances Novel Therapies

Datavault AI Unlocks Real-World Asset Tokenization for Global Investors

Medicus Pharma Highlights Skinject Breakthrough and Pipeline Growth in Oncology

Stardust Power Joins U.S. Lithium Innovation Cluster to Boost Domestic Supply

Medicus Pharma Clarifies Skinject Trial, Advances Toward Next Phase in Skin Cancer

Medicus Pharma Reports Breakthrough Skin Cancer Results and Expands Oncology Pipeline

Medicus Pharma Reports Strong Phase 2 Results for Skinject in Skin Cancer Treatment

Virtuix Signs U.S. Navy Deal to Expand VR Military Training and Simulation | VTIX

ACME Markets Launches Blockchain Lending Platform on Canton Network for Tokenized Assets

Vivos Expands Insurance Coverage for Sleep Apnea Treatment, Targets Profitability

Brittany Kaiser on Privacy AI, Telegram Ecosystem & AlphaTon Capital Strategy

Medicus Pharma Reports Breakthrough Skin Cancer Results and Expands Oncology Pipeline

Roadzen Wins InsurTech Solution of the Year at 2026 FinTech Breakthrough Awards

FreeCast Aims to Solve Streaming Fragmentation With Unified TV Platform | CAST

Datavault AI Partners With Boxing Star Moses Itauma for NIL Digital Asset Platform

Virtuix VR System Selected by U.S. Marines for Combat Training and Mission Planning

Lantern Pharma Launches Zeta AI to Target Rare Cancers and Accelerate Drug Development

Medicus Pharma Reports 73% Clearance in Skin Cancer Trial With Microneedle TechMedicus Commercial2

NRX Pharma Reports 2025 Results, Advances Ketamine Therapy Toward FDA Approval

Roadzen Secures Patent for AI Driver ID Tech to Boost Fleet Safety and Compliance

YY Group Appoints Chief AI Scientist to Advance AI Workforce Platform

Laser Photonics Secures European Order for MarkStar Pro Laser System

New to The Street Partners With IGC Pharma in 12-Part Investor Media Campaign

Virtuix Powers Next-Gen Military VR Training With AI Terrain Simulation | VTIX

NRX Pharma Reports Strong 2025 Results, Eyes FDA Approval for New Therapy

Vivos Therapeutics Study Links Jaw Structure to Sleep Apnea Severity

YesSmile AI Disrupts Dentistry With Faster Treatment Plans and Higher Case Acceptance

SafeTank AI Insurance Platform Targets Tax-Free Growth and Zero Market Loss Strategy

Composer Salvatore Di Vittorio on New Works, NYC Inspiration & Carnegie Hall Performances

Atelier Transforms NYC Lobby with Modern Art Deco Design at 444 Madison Avenue

Virtuix Omni One VR Treadmill Scales with Meta Deal, Gaming, Fitness, and Defense Growth

Datavault AI Reports First Profit and 1,362% Revenue Growth in Record 2025 Results

Sustainable Green Team Launches TeleArborist AI App for Remote Tree Assessments

Lantern Pharma Uses AI to Cut Cancer Drug Costs and Speed Trials With RADAR Platform

New to the Street Renews Media Deal With AI Insurtech Leader Roadzen

Lantern Pharma Uses AI to Transform Cancer Drug Development With Promising Trial Results

Stardust Power Advances $500M Lithium Refinery Project in Oklahoma | 2025 Update

NRX Pharma Advances Toward FDA Approval for Preservative-Free Ketamine Drug

Health In Tech Partners With Cyclum to Expand AI Insurtech Platform Capabilities

NRX Pharma Moves Closer to FDA Approval for NRX-100 With No New Trials Required

BioVie Targets Alzheimer’s, Parkinson’s & Long COVID With Breakthrough Drug Bezisterm

NRX Pharmaceuticals Advances NRX-100 Toward FDA Approval With No New Trials Required

Blackbarn Chef John Doherty Releases Cookbook Celebrating 10 Years of NYC Dining

ThinkEquity Appoints Veteran Trader Michael Messinger to Lead Fixed Income Desk | NewsOut

Acurx Pharma Advances Antibiotic Program Toward Phase 3 C. diff Trials | NewsOut

Medicus Pharma Announces Phase 2 Trial Update Webcast With Lead Investigator | NewsOut

FreeCast CEO Bill Mobley on IPO, AI Streaming Aggregation & Global Expansion

Kled App Pays Users for AI Training Data | Human Data Marketplace Explained